Agilent Technologies said last week that it had licensed a protein labeling reagent and method from the Genomics Institute of the Novartis Research Foundation and that it intends to commercialize the technology.
Agilent Technologies said last week that it had licensed a protein labeling reagent and method from the Genomics Institute of the Novartis Research Foundation and that it intends to commercialize the technology.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.